Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Follow up complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase 1 clinical trial to evaluate the safety and immunogenicity of HIV clade C DNA administered with needlefree jet injector versus needle/syringe and of MF5-adjuvanted clade C Env protein, in healthy, HIV-uninfected adult participants
Description
HVTN 111 is a Phase I clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using DNA-HIV-PT123 and bivalent subtype C gp120 with MF59 administered via biojector and needle/syringe.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.